Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Another Delay On The Way? FDA’s Shuren Says Industry Should ‘Anticipate’ QSR Harmonization To Take ‘Little While Longer’
Agency’s device center director plays coy when asked if FDA will keep “Quality System Regulation” name
Sep 15 2020
•
By
Shawn M. Schmitt
More from Regulation
More from Policy & Regulation